Skip to main content

Table 1 Antimalarial treatment outcomes for the 4ABC Trial [19]

From: Dealing with indeterminate outcomes in antimalarial drug efficacy trials: a comparison between complete case analysis, multiple imputation and inverse probability weighting

TreatmentCuredMissing outcome (indeterminate recurrence)RecrudescenceNew InfectionTotal
AL847 (73.0%) †29 (2.5%)41 (3.5%)243 (21.0%)1,160
ASAQ744 (81.8%)20 (2.2%)18 (2.0%)127 (14.0%)909
DP1,242 (91.2%)13 (1.0%)22 (1.6%)85 (6.2%)1,362
  1. AL artemether-lumefantrine , ASAQ artesunate-amodiaquine , DP dihydroartemisinin-piperaquine
  2. †Percentages are out of total patients treated with that regimen